What our clients say
Engaging Ichor has enabled us to variablize the fixed costs of operating a lab and dedicate our capital to scientific work. Ichor’s responsiveness and thoroughness are unmatched. We rely on their strategic guidance and competent experimental work; truly a partner rather than merely a vendor.
Ichor’s executive team has a unique talent for creative problem-solving and a goal-oriented approach to research. They have built and led several highly effective research initiatives for SENS Research Foundation, with a consistent focus on value creation and actionable endpoints.
Ichor has redefined effective implementation and quality assurance since I began working with them in 2014. Their emphasis on understanding project requirements, coupled with rigorous method development, elevate them head and shoulders above other CROs in the space.
Darren Carpizo MD, PhD Brings His Knowledge and Expertise to Antoxerene Inc. Syracuse, NY, January 29th, 2017 – Antoxerene Inc, an affiliate of Ichor Therapeutics located in LaFayette, NY recently announced the addition of Darren Carpizo MD, PhD to the advisory board of Antoxerene Inc. Carpizo is a world expert on p53, and his knowledge […]
Link to original article By Stan Linhorst StanLinhorst@gmail.com, syracuse.com Kelsey Moody was a medical student at Upstate Medical University when he landed a $540,000 research grant and set up his own pharmaceutical research company. “After we had cleared our first million dollars in funding for the company, I had to choose: Did I want to finish my medical […]
Click for original article Aaron Wolfe expects to finish up his Ph.D. in physics this semester. He has been working on his doctorate since 2011 and should have been done by now, he says, but a few things have gotten in the way—like helping to run a company, Ichor Therapeutics, of which he is chief […]
Please click here for video. LAFAYETTE, N.Y. (WSYR-TV) – One Central New York start-up is looking to start human trials on their solution to macular degeneration– a disease that’s a leading cause of vision loss for over 10 million Americans. Ichor Therapeutics, based in LaFayette, is looking to make a name for itself. “There’s no […]